1. Home
  2. PRPO vs MDRR Comparison

PRPO vs MDRR Comparison

Compare PRPO & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • MDRR
  • Stock Information
  • Founded
  • PRPO N/A
  • MDRR 2015
  • Country
  • PRPO United States
  • MDRR United States
  • Employees
  • PRPO N/A
  • MDRR N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • MDRR Real Estate Investment Trusts
  • Sector
  • PRPO Industrials
  • MDRR Real Estate
  • Exchange
  • PRPO Nasdaq
  • MDRR Nasdaq
  • Market Cap
  • PRPO 12.3M
  • MDRR 13.9M
  • IPO Year
  • PRPO N/A
  • MDRR 2018
  • Fundamental
  • Price
  • PRPO $10.14
  • MDRR $12.56
  • Analyst Decision
  • PRPO
  • MDRR
  • Analyst Count
  • PRPO 0
  • MDRR 0
  • Target Price
  • PRPO N/A
  • MDRR N/A
  • AVG Volume (30 Days)
  • PRPO 13.1K
  • MDRR 4.9K
  • Earning Date
  • PRPO 03-28-2025
  • MDRR 03-05-2025
  • Dividend Yield
  • PRPO N/A
  • MDRR 1.71%
  • EPS Growth
  • PRPO N/A
  • MDRR N/A
  • EPS
  • PRPO N/A
  • MDRR N/A
  • Revenue
  • PRPO $17,411,000.00
  • MDRR $9,916,929.00
  • Revenue This Year
  • PRPO $75.18
  • MDRR N/A
  • Revenue Next Year
  • PRPO N/A
  • MDRR N/A
  • P/E Ratio
  • PRPO N/A
  • MDRR N/A
  • Revenue Growth
  • PRPO 31.31
  • MDRR N/A
  • 52 Week Low
  • PRPO $4.31
  • MDRR $10.60
  • 52 Week High
  • PRPO $10.74
  • MDRR $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 85.00
  • MDRR 49.84
  • Support Level
  • PRPO $7.02
  • MDRR $12.30
  • Resistance Level
  • PRPO $7.54
  • MDRR $13.31
  • Average True Range (ATR)
  • PRPO 0.50
  • MDRR 0.48
  • MACD
  • PRPO 0.29
  • MDRR 0.06
  • Stochastic Oscillator
  • PRPO 85.72
  • MDRR 27.34

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.

Share on Social Networks: